Please assess the completion status of the following clinical trial:

Trial Title: Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female with mild to moderate atopic dermatitis, 2-17 years of age, that agree to participate and provide written consent (and assent if applicable)~* Have an investigator Global Assessment of mild to moderate atopic dermatitis (IGA rating of 2-3 in the Investigator Global Assessment)~* Percentage of overall body surface area of involvement (BSA) must be \> 1% and may include facial and intertriginous skin.~Exclusion Criteria:~* Use within 4 weeks of baseline of systemic anti-inflammatory medication, which may influence study outcome, such as systemic corticosteroids.~* Application or use within 2 weeks of baseline of topical corticosteroid medications or topical anti-inflammatory medication, which may influence study outcome.~* Presence of a concurrent medical condition, which is determined by the investigator to potentially interfere with study outcomes or patient assessments.~* Introduction of any other prescription medication, topical or systemic, for atopic dermatitis while participating int he study (oral antihistamines will be allowed, so long as they are neither initiated nor discontinued during the course of this study)~* Amount of disease involvement that would require \>60gm of cream in a 1 week period~* Subjects with known allergy or sensitivity to Aquaphor Healing Ointment, Atopiclair or EpiCeram or components therein.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Aquaphor Healing Ointment (Type: EXPERIMENTAL): Aquaphor Healing Ointment three times daily to atopic dermatitis
- Atopiclair Nonsteroidal Cream (Type: ACTIVE_COMPARATOR): Atopiclair Nonsteroidal Cream three times daily to atopic dermatitis
- EpiCream Skin Barrier Emulsion (Type: ACTIVE_COMPARATOR): EpiCream Skin Barrier Emulsion three times daily to atopic dermatitis

Based on this trial design, predict the completion outcome and termination type (if applicable).